New UK pancreatic cancer charity to push for timely diagnoses, stronger R&D
This article was originally published in Clinica
A charity has been set up in the UK which aims to improve the timeliness of pancreatic cancer diagnoses and strengthen research into this high-mortality disease by increasing awareness among the public and the medical community. Pancreatic Cancer Action (PCA) argues that in some 90% of cases, the condition has progressed too far for surgery at the time of diagnosis – for the vast majority (82%) of patients, the condition is untreatable and terminal by then. Average life expectancy from diagnosis is 3-6 months, and five-year survival stands at 3% – a situation that has remained unchanged in over 40 years, says the PCA. In addition, pancreatic cancer is the fifth most common cause of cancer death in the UK, yet receives less than 2% of total research funding, according to the PCA. In 2008, there were 7,780 deaths from the disease and almost 7,700 new diagnoses.